This analysis profiles drugs currently being developed for the treatment of arthritis, and examines their clinical trial data, marketing strength, patient potential, and opinion leader insight. It also looks at the future development of the arthritis market in terms of forecast sales, patient potential, and future launches of key pipeline products. With an analysis of both the current and future market, this is a holistic look at the future potential of the arthritis pipeline and the associated opportunities and threats in the market.
